PENAL CODE
SECTION 3500
3500. For purposes of this title:
(a) "Behaviorial research" means studies involving, but not
limited to, the investigation of human behavior, emotion, adaptation,
conditioning, and response in a program designed to test certain
hypotheses through the collection of objective data. Behavioral
research does not include the accumulation of statistical data in the
assessment of the effectiveness of programs to which inmates are
routinely assigned, such as, but not limited to, education,
vocational training, productive work, counseling, recognized
therapies, and programs which are not experimental in nature.
(b) "Biomedical research" means research relating to or involving
biological, medical, or physical science.
(c) "Psychotropic drug" means any drug that has the capability of
changing or controlling mental functioning or behavior through direct
pharmacological action. Such drugs include, but are not limited to,
antipsychotic, antianxiety, sedative, antidepressant, and stimulant
drugs. Psychotropic drugs also include mind-altering and
behavior-altering drugs which, in specified dosages, are used to
alleviate certain physical disorders, and drugs which are ordinarily
used to alleviate certain physical disorders but may, in specified
dosages, have mind-altering or behavior-altering effects.
(d) "Research" means a class of activities designed to develop or
contribute to generalizable knowledge such as theories, principles,
or relationships, or the accumulation of data on which they may be
based, that can be corroborated by accepted scientific observation
and inferences.
(e) "Research protocol" means a formal document setting forth the
explicit objectives of a research project and the procedures of
investigation designed to reach those objectives.
(f) "Phase I drug" means any drug which is designated as a phase I
drug for testing purposes under the federal Food and Drug
Administration criteria in Section 312.1 of Title 21 of the Code of
Federal Regulations.
|